3 ms·
Or, in the case of Valeant Pharmaceuticals they just jacked the prices up after buying smaller drug companies and getting rid of all the R&D teams ... that does
by philjohn 6y ago
Or, in the case of Valeant Pharmaceuticals they just jacked the prices up after buying smaller drug companies and getting rid of all the R&D teams ... that doesn't seem to have incentivized further drug development by them, did it?
- zaphar 6y agoYou are speaking of a specific anecdotal experience and he is talking about the industry in aggregate. Neither of you are invalidating the other's point. The actual facts are in support of the posters point: https://www.abpi.org.uk/facts-and-figures/science-and-innovation/worldwide-pharmaceutical-company-rd-expenditure-by-country/ https://www.abpi.org.uk/facts-and-figures/science-and-innova... But your example is a real occurrence of abuse under the US system.